logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

GolimumabFulminant demyelinating disease: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2020年 / 1809卷 / 1期
关键词:
D O I:
10.1007/s40278-020-79902-6
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:118 / 118
相关论文
共 50 条
  • [21] FingolimodTumefactive demyelinating lesion: case report
    Reactions Weekly, 2023, 1981 (1) : 182 - 182
  • [22] AlemtuzumabTumefactive demyelinating lesion: case report
    Reactions Weekly, 2017, 1650 (1) : 24 - 24
  • [23] FingolimodTumefactive demyelinating lesions: case report
    Reactions Weekly, 2017, 1681 (1) : 155 - 155
  • [24] NivolumabAcute demyelinating polyneuropathy: case report
    Reactions Weekly, 2018, 1701 (1) : 214 - 214
  • [25] FingolimodTumefactive demyelinating lesions: case report
    Reactions Weekly, 2019, 1734 (1) : 230 - 230
  • [26] TozinameranInflammatory demyelinating polyneuropathy: case report
    Reactions Weekly, 2022, 1917 (1) : 549 - 549
  • [27] NivolumabAcute demyelinating polyneuropathy: case report
    Reactions Weekly, 2018, 1687 (1) : 169 - 169
  • [28] AtezolizumabAcute demyelinating polyneuropathy: case report
    Reactions Weekly, 2022, 1888 (1) : 76 - 76
  • [29] IsotretinoinCerebellar demyelinating lesion: case report
    Reactions Weekly, 2008, 1194-1195 (1) : 22 - 22
  • [30] NatalizumabTumefactive demyelinating lesions: case report
    Reactions Weekly, 2019, 1748 (1) : 372 - 372
← 12345 →